z-logo
open-access-imgOpen Access
Convergent and Divergent Pathways Decoding Hierarchical Additive Mechanisms in Treating Cerebral Ischemia–Reperfusion Injury
Author(s) -
Zhang YingYing,
Li HaiXia,
Chen YinYing,
Fang Hong,
Yu YaNan,
Liu Jun,
Jing ZhiWei,
Wang Zhong,
Wang YongYan
Publication year - 2014
Publication title -
cns neuroscience and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 69
eISSN - 1755-5949
pISSN - 1755-5930
DOI - 10.1111/cns.12205
Subject(s) - mechanism (biology) , ischemia , neuroscience , biology , medicine , computational biology , bioinformatics , philosophy , epistemology
Summary Introduction Cerebral ischemia is considered to be a highly complex disease resulting from the complicated interplay of multiple pathways. Disappointedly, most of the previous studies were limited to a single gene or a single pathway. The extent to which all involved pathways are translated into fusing mechanisms of a combination therapy is of fundamental importance. Aims We report an integrative strategy to reveal the additive mechanism that a combination ( BJ ) of compound baicalin ( BA ) and jasminoidin ( JA ) fights against cerebral ischemia based on variation of pathways and functional communities. Results We identified six pathways of BJ group that shared diverse additive index from 0.09 to 1, which assembled broad cross talks from seven pathways of BA and 16 pathways of JA both at horizontal and vertical levels. Besides a total of 60 overlapping functions as a robust integration background among the three groups based on significantly differential subnetworks, additive mechanism with strong confidence by networks altered functions. Conclusions These results provide strong evidence that the additive mechanism is more complex than previously appreciated, and an integrative analysis of pathways may suggest an important paradigm for revealing pharmacological mechanisms underlying drug combinations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here